---
title: "Valrubicin - Malignant tumor of urinary bladder"
sidebar: mydoc_sidebar
permalink: db00385-mesh-d001749-1.html
toc: false 
---


Path ID: `DB00385_MESH_D001749_1`
{% include image.html url="images/db00385-mesh-d001749-1.png" file="db00385-mesh-d001749-1.png" alt="db00385-mesh-d001749-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C016163 | Valrubicin | Drug |
| UniProt:P11388 | DNA topoisomerase 2-alpha | Protein |
| GO:0031052 | chromosomal damage | BiologicalProcess |
| GO:0006412 | protein synthesis | BiologicalProcess |
| GO:0051319 | G2 phase | BiologicalProcess |
| GO:0007049 | cell cycle | BiologicalProcess |
| CL:0001063 | tumor cell | Cell |
| MESH:D001749 | Malignant tumor of urinary bladder | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Valrubicin | DECREASES ACTIVITY OF | Dna Topoisomerase 2-Alpha |
| Dna Topoisomerase 2-Alpha | CAUSES | Chromosomal Damage |
| Chromosomal Damage | NEGATIVELY REGULATES | Protein Synthesis |
| Protein Synthesis | DISRUPTS | G2 Phase |
| G2 Phase | IN PATHWAY WITH | Cell Cycle |
| Cell Cycle | LOCATED IN | Tumor Cell |
| Tumor Cell | CORRELATED WITH | Malignant Tumor Of Urinary Bladder |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00385#mechanismofaction](https://go.drugbank.com/drugs/DB00385#mechanismofaction)
  - [https://pubchem.ncbi.nlm.nih.gov/compound/Valrubicin](https://pubchem.ncbi.nlm.nih.gov/compound/Valrubicin)
